SCHEMBL23929429

SCHEMBL23929429

N=P(C12CC3CC(CC(C3)C1)C2)(C12CC3CC(CC(C3)C1)C2)C12CC3CC(CC(C3)C1)C2

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.48
GRIN2D O15399 5/20 0.38
GRIN3B O60391 5/20 0.38
GRIN1 Q05586 5/20 0.38
GRIN2A Q12879 5/20 0.38
GRIN2B Q13224 5/20 0.38
GRIN2C Q14957 5/20 0.38
GRIN3A Q8TCU5 5/20 0.38
LMNA P02545 2/20 0.38
SLC22A2 O15244 2/20 0.38
SLC47A1 Q96FL8 2/20 0.38
SLC22A1 O15245 1/20 0.38
TSHR P16473 1/20 0.38
NFKB1 P19838 1/20 0.38
STAT6 P42226 1/20 0.38
SIGMAR1 Q99720 1/20 0.38
POLB P06746 1/20 0.36
THRB P10828 1/20 0.36
BLM P54132 1/20 0.36
PMP22 Q01453 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23929406 0.78 EPHX2 (0.45) GAAGRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL5736635 0.65 GAA (1.00) GAAGRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL2825473 0.65 GAA (0.56) GAAGRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL1092162 0.65 GAA (0.56) GAAGRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL1091418 0.65 GAA (0.56) GAAGRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL23929726 0.64 GAA (0.38) GAAGRIN2DGRIN3BGRIN1GRIN2A
Hydrochloric Acid SCHEMBL2825475 0.63 GAA (0.95) GAAGRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL23333268 0.62 PKM (0.48) GAAGRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL148421 0.62 PKM (0.48) GAAGRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL2126658 0.62 PKM (0.48) GAAGRIN2DGRIN3BGRIN1GRIN2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230235100-A1 CYCLOPENTADIENYL/ADAMANTYL PHOSPHINIMINE ZIRCONIUM AND HAFNIUM COMPLEXES NOVA CHEMICALS (INTERNATIONAL) S.A. (CH) 2023-07-27 US disclosed
US-20230235100-A1 CYCLOPENTADIENYL/ADAMANTYL PHOSPHINIMINE ZIRCONIUM AND HAFNIUM COMPLEXES NOVA CHEMICALS (INTERNATIONAL) S.A. (CH) 2023-07-27 US disclosed
EP-4139320-A1 CYCLOPENTADIENYL/ADAMANTYL PHOSPHINIMINE ZIRCONIUM AND HAFNIUM COMPLEXES Nova Chemicals (International) S.A. (CH) 2023-03-01 EP disclosed
WO-2021214612-A1 CYCLOPENTADIENYL/ADAMANTYL PHOSPHINIMINE ZIRCONIUM AND HAFNIUM COMPLEXES NOVA CHEMICALS (INTERNATIONAL) S.A. (CH) 2021-10-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230235100-A1 CYCLOPENTADIENYL/ADAMANTYL PHOSPHINIMINE ZIRCONIUM AND HAFNIUM COMPLEXES HCFC1, AP1M1, AP3M1 GAA 1849/4885GRIN2D 3822/4885GRIN3B 3682/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.